**Question:** A selective a1 blockers chemically distinct from prazosin used as an antihypertensive agent.

**Core Concept:** Selective a1 blockers are a class of medications that specifically target alpha-1 adrenergic receptors, particularly the a1 subtype, to lower blood pressure. They differ from prazosin, a medication used for treating hypertension as well, primarily due to its unique chemical structure and receptor selectivity.

**Why the Correct Answer is Right:** The correct answer, C, refers to medications that are selective a1 blockers and chemically distinct from prazosin, while functioning as antihypertensive agents. These medications aim to lower blood pressure by blocking the a1 receptors, leading to vasodilation and decreased cardiac contractility.

**Why Each Wrong Option is Incorrect:**

A. This option is incorrect because it refers to medications that are selective a1 blockers, but they are not chemically distinct from prazosin. They share similar chemical structures and may not have the same antihypertensive properties as the correct answer.

B. This option is wrong because it mentions selective a1 blockers, but the focus is on an incorrect class or group of medications. The correct answer belongs to a distinct group that differs in both chemical structure and antihypertensive function from prazosin.

D. This option is incorrect because it refers to selective a1 blockers but fails to emphasize their chemical distinctness from prazosin. The correct answer highlights the unique chemical structure and antihypertensive function of these medications.

**Clinical Pearl:** Selective a1 blockers, like other antihypertensive agents, play a crucial role in managing hypertension. They can be used as part of a comprehensive treatment plan, alongside other medications and lifestyle interventions, to reduce blood pressure and prevent complications associated with high blood pressure, such as stroke, heart attack, and heart failure. When choosing a selective a1 blocker, it is essential to consider factors like patient age, comorbidities, and potential drug interactions to ensure optimal treatment outcomes.